Epidemiology of non-steroidal anti-inflammatory drugs consumption in Spain. The MCC-Spain study

dc.contributor.authorGómez Acebo, Inés
dc.contributor.authorDierssen Sotos, Trinidad
dc.contributor.authorPedro, María de
dc.contributor.authorPérez Gómez, Beatriz
dc.contributor.authorCastaño-Vinyals, Gemma
dc.contributor.authorFernández Villa, Tania
dc.contributor.authorPalazuelos-Calderón, Camilo
dc.contributor.authorAmiano, Pilar
dc.contributor.authorEtxeberria, Jaione
dc.contributor.authorBenavente, Yolanda
dc.contributor.authorFernández Tardón, Guillermo
dc.contributor.authorSalcedo Bellido, Inmaculada
dc.contributor.authorCapelo Álvarez, Rocío
dc.contributor.authorPeiró, Rosana
dc.contributor.authorMarcos Gragera, Rafael
dc.contributor.authorHuerta Castaño, José María
dc.contributor.authorTardón, Adonina
dc.contributor.authorBarricarte, Aurelio
dc.contributor.authorAltzibar, Jone M.
dc.contributor.authorAlonso Molero, Jéssica
dc.contributor.authorDávila Batista, Verónica
dc.contributor.authorAragonès Sanz, Núria
dc.contributor.authorPollán, Marina
dc.contributor.authorKogevinas, Manolis
dc.contributor.authorLlorca, Javier
dc.date.accessioned2020-12-01T15:54:50Z
dc.date.available2020-12-01T15:54:50Z
dc.date.issued2018-01-21
dc.date.updated2020-11-11T17:41:07Z
dc.description.abstractBackground: Non-steroidal anti-inflammatory drugs (NSAIDs) are widely used despite their risk of gastrointestinal bleeding or cardiovascular events. We report the profile of people taking NSAIDs in Spain, and we include demographic factors, health-related behaviours and cardiovascular disease history. Methods: Four thousand sixtyparticipants were selected using a pseudorandom number list from Family Practice lists in 12 Spanish provinces. They completed a face-to-face computerized interview on their NSAID consumption, demographic characteristics, body mass index, alcohol and tobacco consumption and medical history. In addition, participants completed a self-administered food-frequency and alcohol consumption questionnaire. Factors associated with ever and current NSAID consumption were identified by logistic regression. Results: Women consumed more non-aspirin NSAIDs (38.8% [36.7-41.0]) than men (22.3 [20.5-24.2]), but men consumed more aspirin (11.7% [10.3-13.2]) than women (5.2% [4.3-6.3]). Consumption of non-aspirin NSAIDs decrease with age from 44.2% (39.4-49.1) in younger than 45 to 21.1% (18.3-24.2) in older than 75, but the age-pattern for aspirin usage was the opposite. Aspirin was reported by about 11% patients, as being twice as used in men (11.7%) than in women (5.2%); its consumption increased with age from 1.7% (< 45 years old) to 12.4% (>= 75 years old). Aspirin was strongly associated with the presence of cardiovascular risk factors or established cardiovascular disease, reaching odds ratios of 15.2 (7.4-31.2) in women with acute coronary syndrome, 13.3 (6.2-28.3) in women with strokes and 11.1 (7.8-15.9) in men with acute coronary syndrome. Participants with cardiovascular risk factors or diseases consumed as much non-aspirin NSAID as participants without such conditions. Conclusions: Non-aspirin NSAIDs were more consumed by women and aspirin by men. The age patterns of aspirin and non-aspirin NSAIDs were opposite: the higher the age, the lower the non-aspirin NSAIDs usage and the higher the aspirin consumption. People with cardiovascular risk factors or diseases consumed more aspirin, but they did not decrease their non-aspirin NSAIDs usage.
dc.format.extent13 p.
dc.format.mimetypeapplication/pdf
dc.identifier.pmid30241493
dc.identifier.urihttps://hdl.handle.net/2445/172462
dc.language.isoeng
dc.publisherBioMed Central
dc.relation.isformatofReproducció del document publicat a: https://doi.org/10.1186/s12889-018-6019-z
dc.relation.ispartofBMC Public Health, 2018, vol. 18
dc.relation.urihttps://doi.org/10.1186/s12889-018-6019-z
dc.rightscc by (c) Gómez Acebo et al., 2018
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/es/
dc.sourceArticles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL))
dc.subject.classificationAspirina
dc.subject.classificationFactors de risc en les malalties
dc.subject.classificationMalalties cardiovasculars
dc.subject.classificationMalalties del tracte gastrointestinal
dc.subject.otherAspirin
dc.subject.otherRisk factors in diseases
dc.subject.otherCardiovascular diseases
dc.subject.otherGastrointestinal system diseases
dc.titleEpidemiology of non-steroidal anti-inflammatory drugs consumption in Spain. The MCC-Spain study
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion

Fitxers

Paquet original

Mostrant 1 - 1 de 1
Carregant...
Miniatura
Nom:
Gomez-AceboI.pdf
Mida:
933.04 KB
Format:
Adobe Portable Document Format